[157 Pages Report] The global next-generation sequencing (NGS) services market is projected to reach USD 2,748.6 Million by 2022 from USD 868.1 Million in 2016, growing at a CAGR of 21.0% during 2017-2022.

To define, describe, and forecast the next-generation sequencing (NGS) services market by type, technology, application, end user, and region

To provide detailed information regarding factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges) along with current trends

To analyze micromarkets with respect to their growth trends, prospects, and contributions to the total market

To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

To forecast the revenue of the market segments with respect to four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World

To profile the key players and comprehensively analyze their market shares and core competencies

To track and analyze competitive developments such as product launches; agreements, partnerships, and collaborations; mergers & acquisitions; and research & development activities in the NGS services market

Research Methodology

This research study involved the usage of extensive secondary sources; directories; and databases such as Hoovers, Bloomberg Business, Factiva, and Avention; along with government databases, to identify and collect information for this technology-based, market-oriented, and commercial study of the next-generation sequencing (NGS) services market. In-depth interviews were conducted with various primary respondents that included key industry participants, subject-matter experts (SMEs), D-level and C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects of the market.

The secondary sources referred to for this research study include corporate filings (such as annual reports, SEC filings, investor presentations, and financial statements); research journals; press releases; as well as articles published by various trade, business, and professional associations

The global next-generation sequencing (NGS) services market is expected to reach USD 2,748.6 Million by 2022 from USD 1,059.2 Million in 2017, growing at a CAGR of 21.0% during the forecast period. Factors such as technological advancements in the field of robot-assisted surgeries, increasing number of minimally-invasive surgeries, and growing patient preference for affordable & effective surgical treatments are driving the growth of this market.

The report analyzes the global NGS services market by type, technology, application, end user, and region. Based on type, the targeted resequencing & custom gene panels segment accounted for the largest share of the market; owing it to the advantages of targeted resequencing it offers over conventional methods and development of technologically advanced NGS products and services for targeted resequencing.

Sequencing by synthesis technology accounted for the largest market share owing to the introduction of technologically advanced SBS platforms in the market which allows more efficient sequencing and reduces the cost of sequencing. Based on applications, the next-generation sequencing (NGS) services market is segmented into diagnostics, drug discovery, biomarker discovery, agriculture & animal research, and other applications. The diagnostics segment is estimated to account for the largest share of the global NGS services market in 2017 owing to its growing number of target diseases across the globe and technological advancements to support a wider range of NGS-based applications.

This report covers the NGS services market value data across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the global NGS services market in 2016, followed by Europe. The large share in the North American region is mainly attributed to the presence of leading NGS service providers in the region, declining cost of sequencing, rising awareness of NGS services, increasing number of NGS-based research & clinical applications in the region, high incidence of target diseases such as cancer, and the favorable reimbursement scenario in the region. The Asia-Pacific region is expected to register the highest growth rate during the forecast period, due to the rapid growth in the genomic research and NGS based diagnostics in emerging Asia-Pacific countries such as China and India, which will support the adoption of NGS services.

The installation of in-house sequencing facilities in hospitals and universities is the key factors restraining the growth of this market.

As of 2016, BGI (China) dominates the market through its wide range of technologically advanced and innovative NGS services. The company adopts the strategy of agreements and partnerships to maintain its leadership position in the market. Other prominent players in the market included Eurofins Scientific SE (Luxembourg), PerkinElmer, Inc. (U.S.), QIAGEN (Germany), Macrogen Inc. (South Korea), GENEWIZ, Inc. (U.S.), Illumina, Inc. (U.S.), Novogene Corporation (China), and GATC Biotech AG (Germany) among others.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst